Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glucose-processing enzymes represent a broad functional class of proteins responsible for the breakdown, synthesis, and modification of glucose and its derivatives. This group includes intestinal enzymes like alpha-glucosidases (e.g., maltase and sucrase), which are essential for digesting complex carbohydrates into absorbable monosaccharides, as well as intracellular enzymes involved in glycolysis (e.g., hexokinase) and gluconeogenesis (e.g., glucose-6-phosphatase) (Source: StatPearls, NIH). Beyond energy metabolism, certain glucose-processing enzymes, such as glucosidase I and II, play a critical role in the N-glycan processing of glycoproteins within the endoplasmic reticulum, a process vital for proper protein folding and viral assembly (Source: PubMed). In clinical practice, these enzymes are primary therapeutic targets for Type 2 diabetes, where inhibitors like acarbose are used to reduce postprandial hyperglycemia by slowing carbohydrate absorption. They are also emerging targets in oncology due to the metabolic reprogramming of cancer cells and in antiviral research, where inhibiting glycan processing can impair the replication of enveloped viruses like Dengue and Hepatitis C (Source: Journal of Virology, Nature Reviews Cancer).
Inhibition of enzymatic activity to modulate carbohydrate digestion, glucose metabolic flux, or glycoprotein maturation.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glucose-processing enzyme.